West Pharmaceutical Services, Inc. vs Abbvie Inc.
WST vs ABBV — side-by-side comparison from reported financials. WST leads 6, ABBV leads 4 of 10 comparable metrics.
West Pharmaceutical Services, Inc.
WST · Healthcare
$366.00+0.75%Mixed
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | WST | ABBV |
|---|---|---|
| Price | $366.00 | $276.43 |
| Market cap | $25.8B | $488B |
| Revenue (TTM) | $3.33B | $64.4B |
| Revenue growth | +2.1% | +1.8% |
| Net margin | 17.0% | 9.8% |
| Free cash flow | $437M | $18.2B |
| Net cash (debt) | $589M | ($56.2B) |
| 1-year price return | +38.9% | +19.8% |
| P/E | 47.7 | 77.4 |
| P/E vs own history (cheap-side %) | 39% | 23% |
| Dividend yield | 0.23% | 2.45% |
| Return on equity | 19% | 96% |
| Altman Z-score | — | 2.33 |
| CV checks passed | 9 of 11 | 9 of 11 |
| Employees | 10,800 | 57,000 |
Full résumé-style profiles: WST CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.